Kamal Faisal, Khan Muhammad Ali, Lee-Smith Wade, Sharma Sachit, Acharya Ashu, Farooq Umer, Gangwani Manesh Kumar, Saeed Aamir, Aziz Muhammad, Hayat Umar, Saleem Nasir, Kumar Anand, Schlachterman Alexander, Kowalski Thomas
Division of Gastroenterology, Thomas Jefferson University Hospital, Philadelphia, PA.
Department of Gastroenterology, Hepatology and Nutrition, University of Texas MD Anderson Cancer Center, Houston, TX.
J Clin Gastroenterol. 2025 Jan 1;59(1):47-53. doi: 10.1097/MCG.0000000000002080.
Co-axial plastic double pigtail stents (DPSs) are commonly placed through lumen apposing metal stents (LAMS) in patients with pancreatic fluid collections (PFCs) to decrease the risk of adverse events. In this meta-analysis, we have compared the outcomes of LAMS plus co-axial DPS versus LAMS alone in patients with PFCs.
We reviewed several databases to identify the studies that compared outcomes of LAMS with DPS to LAMS without DPS in the treatment of PFCs. Our outcomes of interest were overall adverse events, clinical success and individual adverse events such as stent (LAMS) migration, stent occlusion, bleeding, and infection. We calculated pooled risk ratios (RR) with 95% confidence intervals (CIs) for the analysis of outcomes. We used a random effects model to analyze the data. Heterogeneity was assessed using the I 2 statistic.
We included 10 studies with 685 patients. Rate of overall adverse events was significantly lower in the LAMS+DPS group compared with LAMS alone, RR (95% CI) 0.58 (0.40, 0.87). There was no significant difference in the rate of clinical success between groups, RR (95% CI) 1.03 (0.94, 1.13). We found no significant difference in rate of stent occlusion between groups. Rate of infection was significantly lower in LAMS+DPS group, RR (95% CI) 0.46 (0.24, 0.85). There was no significant difference in rate of bleeding and stent (LAMS) migration between groups.
Addition of co-axial DPS to LAMS decreases the risk of adverse events in patients with PFCs and should be considered in all patients with PFCs.
对于胰腺液体积聚(PFC)患者,同轴塑料双猪尾支架(DPS)通常通过管腔贴附金属支架(LAMS)置入,以降低不良事件风险。在这项荟萃分析中,我们比较了LAMS联合同轴DPS与单纯LAMS用于PFC患者的治疗效果。
我们检索了多个数据库,以确定比较LAMS联合DPS与未联合DPS治疗PFC效果的研究。我们感兴趣的结局包括总体不良事件、临床成功率以及诸如支架(LAMS)移位、支架闭塞、出血和感染等个体不良事件。我们计算了合并风险比(RR)及95%置信区间(CI)以分析结局。我们采用随机效应模型分析数据。使用I²统计量评估异质性。
我们纳入了10项研究,共685例患者。与单纯LAMS组相比,LAMS + DPS组的总体不良事件发生率显著更低,RR(95% CI)为0.58(0.40,0.87)。两组间临床成功率无显著差异,RR(95% CI)为1.03(0.94,1.13)。我们发现两组间支架闭塞率无显著差异。LAMS + DPS组的感染率显著更低,RR(95% CI)为0.46(0.24,0.85)。两组间出血率和支架(LAMS)移位率无显著差异。
LAMS联合同轴DPS可降低PFC患者的不良事件风险,所有PFC患者均应考虑使用。